Literature DB >> 25665773

Failed back surgery syndrome: what's in a name? A proposal to replace "FBSS" by "POPS"….

P Rigoard1, M J Desai2, R S Taylor3.   

Abstract

BACKGROUND: The current definition of Failed Back Surgery Syndrome (FBSS) has a pejorative and restrictive connotation of blame and failure. Optimally, the evaluation of FBSS patients might be based on a multidimensional approach, involving an array of practitioners including spine surgeons, pain physicians, physiotherapists and behavioural specialists. Even though these clinical interactions should lead to a unique approach, one main problem comes from the fact that FBSS definition has varied over time and remains extremely controversial. There is now a need for global consensus about what we call FBSS, why, when and how. Discussing the name of this syndrome appears to be a logical starting point. DISCUSSION: "PostOperative Persistent Syndrome", summarised by the acronym "POPS", could be an appropriate term to not only encapsulate failure but pain, function and psychosocial dysfunction following unsuccessful spine surgery whether from a technical or expectation standpoint. A return to the source might help to identify the real clinical problem, i.e. the pain mechanism: nociceptive, neuropathic pain or mixed. A clinical and radiological spine assessment is key to ensure that no further surgery is required, by distinguishing within the so-called FBSS population, "true" FBSS patients and "potential" FBSS patients, who are actually not FBSS patients, as an aetiological treatment of potential pain generators still remains possible.
CONCLUSION: We propose to replace the FBSS acronym by POPS. The ultimate goal of this redefinition would be to guide the patient towards the future rather than the past and to reach a consensus, based on network discussions, concerning the following items: integrate pain mechanisms into the diagnostic process; implement the notion of a predominant ratio between mechanical/neuropathic pain mechanisms, which defines the potential target for treatment options; create a network supported by a database, to prospectively pool and analyse data, using homogeneous evaluation tools and ultimately define outcome predictors in this population.
Copyright © 2015 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Chirurgie du rachis; Chronic pain; Douleurs chroniques; Evaluation; Failed Back Surgery Syndrome; Lombo-radiculalgies postopératoires; Spinal cord stimulation; Spine surgery; Stimulation médullaire épidurale; Taxonomie; Taxonomy; Évaluations

Mesh:

Year:  2015        PMID: 25665773     DOI: 10.1016/j.neuchi.2014.12.001

Source DB:  PubMed          Journal:  Neurochirurgie        ISSN: 0028-3770            Impact factor:   1.553


  10 in total

1.  The dimensions of "failed back surgery syndrome": what is behind a label?

Authors:  Ralf Weigel; Hans-Holger Capelle; Shadi Al-Afif; Joachim K Krauss
Journal:  Acta Neurochir (Wien)       Date:  2020-09-01       Impact factor: 2.216

2.  Effect of Previous Caudal Block to Predict Successful Outcome after Adhesiolysis using a Steerable Catheter in Lumbar Failed Back Surgery Syndrome: A Retrospective Study.

Authors:  Ji Yeong Kim; Do-Hyeong Kim; Dong Woo Han; Young Chan Kim; Ji Young Lee; Young Kyung Park; Hue Jung Park
Journal:  Int J Med Sci       Date:  2022-06-06       Impact factor: 3.642

3.  The appropriate management of persisting pain after spine surgery: a European panel study with recommendations based on the RAND/UCLA method.

Authors:  Volker M Tronnier; Sam Eldabe; Jörg Franke; Frank Huygen; Philippe Rigoard; Javier de Andres Ares; Richard Assaker; Alejandro Gomez-Rice; Marco La Grua; Maarten Moens; Lieven Moke; Christophe Perruchoud; Nasir A Quraishi; Dominique A Rothenfluh; Pedram Tabatabaei; Koen Van Boxem; Carmen Vleggeert-Lankamp; Björn Zoëga; Herman J Stoevelaar
Journal:  Eur Spine J       Date:  2018-08-04       Impact factor: 3.134

4.  Failed back surgery syndrome: review and new hypotheses.

Authors:  Bruno Bordoni; Fabiola Marelli
Journal:  J Pain Res       Date:  2016-01-12       Impact factor: 3.133

Review 5.  Neuropathic Pain after Spinal Surgery.

Authors:  Jae Hwan Cho; Jae Hyup Lee; Kwang-Sup Song; Jae-Young Hong
Journal:  Asian Spine J       Date:  2017-08-07

6.  Effectiveness of and Factors Associated with Balloon Adhesiolysis in Patients with Lumbar Post-Laminectomy Syndrome: A Retrospective Study.

Authors:  Yul Oh; Dong Ah Shin; Dong Joon Kim; Woojong Cho; Taejun Na; Jeong-Gil Leem; Jin-Woo Shin; Doo-Hwan Kim; Kyung-Don Hahm; Seong-Soo Choi
Journal:  J Clin Med       Date:  2020-04-16       Impact factor: 4.241

Review 7.  Optimizing the Management and Outcomes of Failed Back Surgery Syndrome: A Proposal of a Standardized Multidisciplinary Team Care Pathway.

Authors:  Kliment Gatzinsky; Sam Eldabe; Jean-Philippe Deneuville; Wim Duyvendak; Nicolas Naiditch; Jean-Pierre Van Buyten; Philippe Rigoard
Journal:  Pain Res Manag       Date:  2019-07-08       Impact factor: 3.037

8.  Persistent Spinal Pain Syndrome: A Proposal for Failed Back Surgery Syndrome and ICD-11.

Authors:  Nick Christelis; Brian Simpson; Marc Russo; Michael Stanton-Hicks; Giancarlo Barolat; Simon Thomson; Stephan Schug; Ralf Baron; Eric Buchser; Daniel B Carr; Timothy R Deer; Ivano Dones; Sam Eldabe; Rollin Gallagher; Frank Huygen; David Kloth; Robert Levy; Richard North; Christophe Perruchoud; Erika Petersen; Philippe Rigoard; Konstantin Slavin; Dennis Turk; Todd Wetzel; John Loeser
Journal:  Pain Med       Date:  2021-04-20       Impact factor: 3.750

9.  Evaluation of pulsed electromagnetic field therapy for the treatment of chronic postoperative pain following lumbar surgery: a pilot, double-blind, randomized, sham-controlled clinical trial.

Authors:  Robert Gordon Sorrell; Jamie Muhlenfeld; John Moffett; Gary Stevens; Steven Kesten
Journal:  J Pain Res       Date:  2018-06-22       Impact factor: 3.133

Review 10.  Narcotic Addiction in Failed Back Surgery Syndrome.

Authors:  Yuan-Chuan Chen; Ching-Yi Lee; Shiu-Jau Chen
Journal:  Cell Transplant       Date:  2018-08-31       Impact factor: 4.064

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.